Medical Product Logistics and Expedited Delivery

The contract governs the expedited and traceable transportation of pharmaceuticals using non-parcel post methods to ensure timely, secure delivery of medical products under FOB Destination terms, meaning the seller retains ownership and responsibility until the goods arrive at the designated destination. Proof of delivery is mandatory to verify receipt and maintain accountability throughout the supply chain, with all shipments subject to strict logistical controls to safeguard the integrity of temperature-sensitive and high-value pharmaceuticals. The service is contracted under the NAICS code 484220 for specialized freight transportation and is managed as a subcontract by the Defense Logistics Agency under the Department of Defense to support critical healthcare needs. The agreement is linked to the award reference SPE2D926F7401 and is part of a broader logistics effort coordinated by the Defense Logistics Agency, with performance obligations tied to federal procurement standards and compliance requirements for defense medical supply chains. Although specific locations and points of contact are not detailed, delivery must occur across authorized U.S. military and healthcare sites under the agency's operational framework, ensuring uninterrupted access to essential pharmaceuticals. The contract was posted on July 16, 2026, and is structured to enable rapid response capabilities in both routine and emergency medical supply scenarios.